Nordic Bioproducts Group was founded by Olli Kähkönen and Olli Dahl
Central to our work is reducing the world’s reliance on virgin and fossil-based resources, achieving new circular solutions, and enabling impact at scale.
The time is now.


The Company
Born from Aalto University, we are a spin-off that is boldly charging into the future. We partner with the most forward-thinking scientists, companies, industrial leaders, and innovators to unleash the potential of cellulose, biomaterials, and biotechnologies – driving the green transition forward with passion and purpose.
From our groundbreaking, patented AaltoCellTM technology and Norratex fiber innovation – to BIG, our bio innovation garage – we collaborate to discover and develop sustainable, cellulose-based solutions for a better world.
Our dedication to innovation and sustainability drives us to push boundaries and create a positive impact in the world, one step at a time.

Our story
Operative laboratory work starts
Own laboratory was built, the birth of BIG
First commercial R&D projects
Team of 10 academics
CMPC collaboration & equity investment, (Norratex™ project)
Business Finland funding for piloting plant
Lappeenranta pilot factory building starts
Team of 15 academics
Taaleri equity investment
NBG selected as a member of EU Horizon PESCO-UP project
Team of 25 academics
BIG facility for R&D and piloting ready
Commercial production begins for our flagship Microcrystalline Cellulose

Together we can make the future.
Leadership




Board of Directors





Next generation
of MCC
Discover purity and excellence like never before with our Microcrystalline Cellulose – setting new standards in quality and performance.

Better products for
people, business and planet.
At the crossroads of creativity and cutting-edge technology, our solutions transcend boundaries, reaching across diverse industries – from food and pharmaceuticals to cosmetics, and more.
News & Stories

In the news: Pioneering Sustainability in Pharma Excipients

Nordic Bioproducts Group named Finalist at CPHI Pharma Awards 2024 in Sustainability

Nordic Bioproducts Group Receives Pharmaceutical Industry’s EXCiPACT® Certification for MCC Production at New Lappeenranta Facility

Nordic Bioproducts Group is recognised by Japan’s Marubeni Corporation as a key innovator to drive the Green Transition

Nordic Bioproducts Group opens its first major production facility for advanced cellulosic materials

Nordic Bioproducts Group and Thailand’s PTT MCC Biochem Co. Ltd. forge a strategic partnership to advance bioplastic innovation for everyday items

Nordic Bioproducts Group Announces its Participation in the EU PESCO-UP project to Transform the Textile Recycling Industry

Marubeni Corporation and Nordic Bioproducts Group Forge a Partnership to Collaborate on the Sustainable Utilization of Biomass

See you at Food Ingredients Europe, 28th-30th November 2023
